How many studies have been conducted on Interferon Beta 1a?

BiohacksAI has indexed 296 PubMed studies on Interferon Beta 1a, including 85 randomized controlled trials (RCTs). 77% of studies involve human subjects.

What are the main research areas for Interferon Beta 1a?

The primary research domains for Interferon Beta 1a are 🛡️ Immunity, 😴 Sleep, ⏳ Longevity & Aging. This is based on analysis of 296 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Interferon Beta 1a

An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.

296+ PubMed studies analyzed · 85 RCTs · Evidence Score: 58.1

Research Domains

Interferon Beta 1a has been studied across 17 research domains including 🛡️ Immunity, 😴 Sleep, ⏳ Longevity & Aging, 🔬 Inflammation, 🔬 Oncology. The primary research focus is 🛡️ Immunity with 98% of studies addressing this area.

Loading evidence profile...

This evidence profile for Interferon Beta 1a is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.